Investor Deep Dive: Molecular You

About Molecular You: Molecular You stands at the forefront of healthcare innovation as the first and only multi-biomarker analytics platform. With a focus on providing decision support to clinicians and ACOs, Molecular You offers highly accurate predictive risk profiles in 26+ health areas. Their groundbreaking low-cost molecular AI-powered blood analytics platform leverages quantitative proteomics and metabolomics, boasting an 800+ biomarker assay. This data feeds into an algorithm-driven software program, delivering precise predictive risk profiles for 26 health conditions, with more in development. Key Highlights: Unveiling Molecular You's Breakthrough Technology Decoding Health Mechanisms at the Molecular Level Data-Driven Decision Making Investment Opportunities: Explore potential investment opportunities in the rapidly evolving healthcare sector. Learn how Molecular You's disruptive technology is poised to reshape the industry landscape and unlock new avenues for growth and innovation. Presenter Spotlight: Rob Fraser, Ph.D., CSO + President, Co-founder Rob was the founding CEO and is the current President and CSO of Molecular You Corporation. Backed by his expertise in molecular diagnostics, molecularly targeted drug discovery and development, biochemistry and regulatory compliance, Rob Fraser drives the innovation behind Molecular You’s multi-biomarker analytics. He established a low cost method of measuring hundreds of biomarkers from a single blood sample, along with establishing an LLM model to incorporate the world’s leading scientific literature. Rob has also been involved in leading drug discovery and development projects at Sanofi, Xenon, Neuromed and CDRD. Rob received extensive training in the molecular mechanisms of endocrinology while completing his Ph.D. at the University of Alberta and Harvard Medical School and Post-Doctoral Fellowships at Hospital for Sick Children, Toronto and IGBMC, Strasbourg, France. In addition to Rob’s scientific a